“COMPARISON OF THE EFFECT OF SILDENAFIL AND TADALAFIL ON PULMONARY HYPERTENSION ASSOCIATED WITH HEMODYNAMICALLY SIGNIFICANT PDAS TREATMENT OF PULMONARY HYPERTENSION IN HS-PDA PATIENTS”. Journal of Pharmaceutical Negative Results (December 11, 2022): 3266–3274. Accessed June 9, 2026. https://mail.pnrjournal.com/index.php/home/article/view/4563.